356 related items for PubMed ID: 12700961
1. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[Abstract] [Full Text] [Related]
2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
3. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P, Bagga A, Jindal N, Srivastava RN.
Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
[Abstract] [Full Text] [Related]
4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
5. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.
Mantan M, Sriram CS, Hari P, Dinda A, Bagga A.
Pediatr Nephrol; 2008 Sep; 23(9):1495-502. PubMed ID: 18566839
[Abstract] [Full Text] [Related]
6. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
Besbas N, Topaloglu R, Saatci O, Bakkaloglu A.
Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
[Abstract] [Full Text] [Related]
7. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[Abstract] [Full Text] [Related]
8. Late resistance to corticosteroids in nephrotic syndrome.
Srivastava RN, Agarwal RK, Moudgil A, Bhuyan UN.
J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
[Abstract] [Full Text] [Related]
9. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis.
Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S.
Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995
[Abstract] [Full Text] [Related]
10. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W, Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Pediatr Nephrol; 2008 Sep; 23(9):1483-93. PubMed ID: 18481113
[Abstract] [Full Text] [Related]
11. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR, Vijaykumar M, Prahlad N, Jain DV.
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[Abstract] [Full Text] [Related]
12. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
Caletti MG, Gallo G, Zumino D, Díaz MA, Vitacco M.
Bol Med Hosp Infant Mex; 1981 Jan; 38(3):457-72. PubMed ID: 7271977
[Abstract] [Full Text] [Related]
13. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
14. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
15. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Picazo ML, Navarro M.
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[Abstract] [Full Text] [Related]
16. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF, Farine M, Thorner P, Baumal R.
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[Abstract] [Full Text] [Related]
17. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F, Ahmad TM, Anwar S.
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[Abstract] [Full Text] [Related]
18. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis?
Mitwalli AH.
Nephrol Dial Transplant; 1998 Jun; 13(6):1524-8. PubMed ID: 9641186
[Abstract] [Full Text] [Related]
19. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
20. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
Prasad N, Gulati S, Sharma RK, Singh U, Ahmed M.
Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
